McKesson/AmeriSource merger raises stakes in FTC review of industry consolidation.
This article was originally published in The Tan Sheet
Executive Summary
McKESSON/AMERISOURCE MERGER RAISES STAKES IN FTC REVIEW of consolidation in the drug wholesaler industry. The Federal Trade Commission is in the process of reviewing Cardinal Health's proposed merger with Bergen Brunswig, which would allow Cardinal to surpass McKesson as the largest wholesaler in the U.S. ("The Tan Sheet" Sept. 1, p. 9). Should the AmeriSource merger also go through, McKesson would regain its number one position.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning